The ASQ and R-PDQ telephone-administered validation within the OTIS antidepressant in pregnancy study.
This study aimed to assess the telephone administration of the 12-month Ages and Stages Questionnaire (ASQ) and the 9- to 24-month Revised Prescreening Denver Questionnaire (R-PDQ) using the Antidepressants in Pregnancy Study cohort from the Organization of Teratology Information Specialists. The ASQ includes five domains (communication, gross motor, fine motor, problem-solving, and personal-social). The R-PDQ tests four areas of development (gross motor, fine motor, personal-social, and language). Both instruments were self and telephone-administered to mothers at 12 months postpartum. Concordance between the telephone and self-administration was assessed with intraclass correlation coefficients (ICCs) with 95% CIs. For the ASQ, concordance between test scores was substantial for the communication scale (ICC = 0.76, 95% CI [0.63, 0.85]), almost perfect for the gross motor scale (ICC = 0.83, 95% CI [0.73, 0.89]), and moderate for the fine motor, problem-solving, and personal-social scales (ICC = 0.43, 95% CI [0.19, 0.61]; ICC = 0.42, 95% CI [0.19, 0.61]; and ICC = 0.50, 95% CI [0.29, 0.67], respectively). Regarding the R-PDQ, concordance between test scores was as follows: gross motor (ICC = 0.90, 95% CI [0.83, 0.94]), language (ICC = 0.57, 95% CI [0.36, 0.73]), and personal-social scales (ICC = 0.26, 95% CI [0.00, 0.49]). For the fine motor scale, the correlation between both modes was 100%. The 12-month ASQ telephone administration could be an alternative for children developmental screening. Except the personal-social scale, the 9- to 24-month R-PDQ could be telephone-administered for prescreening development.
Faculty of Pharmacy, University of Montreal.
Fatiha
F
Karam
Research Center, CHU Ste-Justine.
Odile
O
Sheehy
Research Center, CHU Ste-Justine.
Marie-Claude
MC
Huneau
MotherToBaby and Department of Pediatrics, University of California, San Diego.
Christina
C
Chambers
Department of Obstetrics and Gynecology, University of Montreal.
William D
WD
Fraser
MotherToBaby and Department of Pediatrics, University of California, San Diego.
Diana
D
Johnson
MotherToBaby and Department of Pediatrics, University of California, San Diego.
Kelly
K
Kao
IMAGe Center, Deparment of Pharmacy, CHU Ste Justine.
Brigitte Z
BZ
Martin
College of Pharmacy, University of Arizona.
Sara H
SH
Riordan
Pregnancy Risk Network, NYS Teratogen Information Service.
Mark
M
Roth
Department of Psychiatry, University of Montreal.
Martin
M
St-André
Connecticut Pregnancy Exposure Information Service, University of Connecticut Health Center.
Sharon Voyer
SV
Lavigne
Texas Teratogen Information Service, University of North Texas.
Lori
L
Wolfe
Faculty of Pharmacy, University of Montreal.
Anick
A
Bérard
D000328:Adult; D000928:Antidepressive Agents / Q000627:therapeutic use; D002657:Child Development; D005260:Female; D006801:Humans; D007223:Infant; D065886:Neurodevelopmental Disorders / Q000175:diagnosis*; D011247:Pregnancy; D011795:Surveys and Questionnaires / Q000592:standards*; D013689:Telephone
D000928:Antidepressive Agents